• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA USA, INC. LEAD MODEL 302

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA USA, INC. LEAD MODEL 302 Back to Search Results
Model Number 302-20
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Code Available (3191)
Event Date 01/01/2018
Event Type  Injury  
Event Description
The patient's neurologist provided clinic notes for surgery referral indicating that the patient has some gagging with vns swipe, as well as increased prominence of lead in left side of neck, with some tenderness to palpation.The patient still feels vns stimulation.The lead was very superficial with a sharp edge protruding through but not piercing the skin.The patient has neck pain and it is a concern that there is migration of the lead laterally, as well as migration of the vns in the chest.It was questioned if the patient has encountered a loss of efficacy both with normal output current stimulation and the magnet swipe as the patient had experienced an increase in seizures.The neurologist followed up with an ent surgeon for an evaluation to assess the leads.Additional information was received from the neurologist stating that the cause of the lead protrusion, migration, dysphagia, increased seizures, loss of efficacy, and pain in the left neck was unknown.The patient was experiencing an increase in seizures that was below pre-vns levels.There were no factors such as trauma or manipulation that could have contributed to the events, and lead and generator migration as well as loss of efficacy were the contributing factors for the patient¿s surgery referral.The patient's gagging, protrusion and tenderness in the left neck were not contributing factors for the patient's surgery referral.The generator¿s most recent battery status was stated to not be at end of life.No other relevant information has been received to date.No known surgical intervention has occurred to date.
 
Event Description
The patient received a generator replacement and the generator was disposed of after surgery.There was no repositioning of the new generator and a new pocket was not created.No other relevant information has been received to date.No known surgical intervention for the lead has occurred to date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEAD MODEL 302
Type of Device
LEAD
Manufacturer (Section D)
LIVANOVA USA, INC.
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
LIVANOVA USA, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
njemile crawley
100 cyberonics blvd
suite 600
houston, TX 77058
2812287200
MDR Report Key7490466
MDR Text Key107468903
Report Number1644487-2018-00732
Device Sequence Number1
Product Code LYJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/07/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/31/2008
Device Model Number302-20
Device Lot Number1255
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Event Location Other
Date Manufacturer Received06/01/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/11/2005
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age44 YR
-
-